Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis
Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis have?
Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis has 144 citations in the OpenAlex counts ScholarIQ stores.
When was Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis published?
Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis has 2009 year in the ScholarIQ index.
What is the open-access status of Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis?
Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis has bronze oa status in the ScholarIQ index.
What is the DOI of Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis?
The DOI for Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis is on the source record.
What is the PMID of Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis?
The PMID for Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis is on the source record.
What is the OpenAlex record for Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis?
The OpenAlex for Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis is on the source record.